Aptar

Transforming ideas into solutions that improve everyday life

[Aptar @aptar]

Aptar Pharma announces three new international patent applications focused on inhaled and nasal GLP-1 delivery, strengthening its capabilities in biologics delivery. Read full press release - https://t.co/ju6AIZwJxX #DrugDelivery #Innovation #GLP1 #Biologics

[Aptar @aptar]

Aptar’s EVP & CFO, Vanessa Kanu, was recently featured in an article by CPA Ontario. In the feature, Vanessa shares her perspective on the evolving role of the CFO. Read the full article here: https://t.co/9PQKdLIB79

[Aptar @aptar]

Interest in #NoseToBrain delivery is accelerating - but reliable delivery remains a key challenge.
In this Q&A, Reenal Gandhi shares insights on anatomy, delivery variability & why device–formulation alignment matters. https://t.co/2ocQj3UvB7 #CNS #DrugDelivery #AptarPharma

[Aptar @aptar]

A recap from #ARVO2026. Thank you to everyone who visited Aptar Pharma's booth and connected with us during this year’s event. Watch our recap video for highlights from the conversations and innovation shared in eye care. #AptarPharma #Ophthalmology #PreservativeFree

[Aptar @aptar]

How is the #pMDI evolving with low‑GWP propellants? #AptarPharma's new article explores how the shift is impacting formulation, valve design, manufacturing & regulatory readiness - and how ZEN30 Futurity® supports this transition. https://t.co/KoHoxgrxZN #Inhalation

[Aptar @aptar]

Thanks for joining us at #VitafoodsEurope2026 this week. Three engaging days exploring how innovative delivery formats, user‑centric design & more sustainable solutions can support differentiated nutraceutical portfolios. See you next time! #AptarPharma #Nutraceuticals

[Aptar @aptar]

Aptar Pharma announces continued progress on its awarded research contract with the U.S. FDA focused on advancing scientific understanding related to the transition of metered dose inhalers (MDIs) toward next-generation propellants (NGPs). https://t.co/tRODmSUFmn #AptarPharma

[Aptar @aptar]

We are honored to have won a DIELINE Award in the Sustainable Design – Health, Body & Beauty category, alongside our brand partner Groupe Clarins for the packaging of the Total Eye Lift Eye Cream. https://t.co/mIMipMa2dX

#AptarBeauty #DIELINEAwards #BeautyPackaging

[Aptar @aptar]

Attending the Nasal Formulation & Delivery Summit in Boston, May 19-21? Don't miss Aptar Pharma's presentation on formulation & device considerations for intranasal delivery on Wednesday, May 20 at 10 AM. See you there! #NasalDrugDelivery #Formulation #CombinationProducts

[Aptar @aptar]

Greetings from ARVO 2026! Meet the #AptarPharma team at Booth 6023 and discover our preservative-free solutions that are shaping the future of ophthalmic #drugdelivery, including our Ophthalmic Squeeze Dispenser (OSD) and Beat the Blink™ technologies. See you there! #Eyecare

[Aptar @aptar]

Aptar Reports First Quarter 2026 Results https://t.co/Orml70sZ9o

[Aptar @aptar]

Attending RDD US 2026 from May 10-14? Don't miss #AptarPharma's interactive workshop Tuesday, May 12, which will explore key considerations in inhaled biologic development, from early formulation thinking to delivery strategy. Hope to see you there. #RDD2026 #InhalationDelivery

[Aptar @aptar]

Want to advance your #nutraceuticals portfolio?​ Meet #AptarPharma at #Vitafoods Europe2026. Learn how we can help elevate your differentiated product offerings & help bring your formulation to life with our innovations, from oral spray pumps to drop dispensing systems.

[Aptar @aptar]

Aptar Declares Quarterly Dividend
https://t.co/VxJxZfveEO

[Aptar @aptar]

Join #AptarPharma at #ARVO2026! Stop by Booth 6023 to meet our team and learn how our science-based approach in developing innovative ophthalmic solutions is enhancing the preservative-free user experience.​ #Ophthalmic #OphthalmicSqueezeDispenser #BeattheBlink #PreservativeFree

[Aptar @aptar]

This #EarthDay we’re proud to share that Aptar has been recognized by USA Today as one of America’s Climate Leaders for the 4th consecutive year.
Learn more: https://t.co/AJ5WZ5tcSB

[Aptar @aptar]

Join #AptarPharma, Conference Supporter at #RDDUS2026. Meet our team at Table 1 to connect and exchange perspectives on the future of respiratory drug delivery. Looking forward to meeting you there! #DrugDelivery #Inhalation #CombinationProducts

[Aptar @aptar]

At Noble, the focus is clear: empowering patients to manage their treatments with confidence. Because when patients feel confident, adherence improves & outcomes follow. Learn about Noble’s mission & the value they deliver to partners & patients daily: https://t.co/sOJ84Vd2wx

[Aptar @aptar]

Meet #AptarPharma at #INTERPHEX2026 Booth 1253! Discover why we're your go‑to drug delivery partner, from formulation to patient. Learn how #AptarDigitalHealth is enhancing #patientexperiences & how #AptarPharmaServices can help accelerate & derisk the #drugdevelopment journey.

[Aptar @aptar]

Our EVP & CFO, Vanessa Kanu, recently represented Aptar at The Globe and Mail’s panel discussion on the rapidly changing role of the CFO. Watch the full panel discussion here:
https://t.co/vVJAxEnlVv